Loomis, Sayles & Company’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-193
Closed -$5K 1019
2023
Q2
$5K Buy
+193
New +$4.86K ﹤0.01% 866
2021
Q4
Sell
-78
Closed -$10K 896
2021
Q3
$10K Buy
+78
New +$11.4K ﹤0.01% 815
2021
Q2
Sell
-55
Closed -$10K 908
2021
Q1
$10K Sell
55
-64
-54% -$14.8K ﹤0.01% 793
2020
Q4
$24K Buy
+119
New +$24.2K ﹤0.01% 613
2019
Q2
Sell
-436,970
Closed -$24.3M 732
2019
Q1
$24.3M Sell
436,970
-23,635
-5% -$1.44M 0.05% 171
2018
Q4
$22.8M Buy
460,605
+7,791
+2% +$477K 0.05% 154
2018
Q3
$39.1M Sell
452,814
-145,799
-24% -$10.4M 0.08% 104
2018
Q2
$34.7M Sell
598,613
-154,635
-21% -$7.55M 0.07% 133
2018
Q1
$30.4M Sell
753,248
-26,670
-3% -$1.01M 0.06% 152
2017
Q4
$27.2M Sell
779,918
-7,129
-0.9% -$237K 0.06% 190
2017
Q3
$26.1M Buy
787,047
+67,512
+9% +$2.21M 0.06% 211
2017
Q2
$25M Sell
719,535
-21,090
-3% -$615K 0.06% 207
2017
Q1
$18.5M Buy
+740,625
New +$15.4M 0.05% 269

Other funds holding TDOC

Loomis, Sayles & Company's TDOC Position: Q3 2023 in Review

Loomis, Sayles & Company sold out of Teladoc Health (TDOC) in Q3 2023, closing a stake of 193 shares — an estimated $5K sold.

Loomis, Sayles & Company first reported a position in TDOC in Q1 2017 and held it in 13 quarters. The position peaked at $39.1M in Q3 2018. 436 funds tracked by Wall St. Rank hold TDOC as of Q3 2023.

  • Loomis, Sayles & Company reported no remaining Teladoc Health position as of Q3 2023 after selling out during the quarter.
  • Loomis, Sayles & Company sold 193 Teladoc Health shares in Q3 2023, an estimated $5K.
  • Loomis, Sayles & Company first reported a position in Teladoc Health in Q1 2017 and held it in 13 quarters.
  • Loomis, Sayles & Company's Teladoc Health position peaked at $39.1M in Q3 2018.
  • 436 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2023.

Based on Loomis, Sayles & Company's 13F filing for Q3 2023, filed 9 Nov 2023.